Categories
All News

Global Gene Therapy Market (by Cell Type, Vector Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024. Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth. The market is anticipated to experience certain trends like rapid adoption of personalized medicine, growing occurrence of genetic disorders, advancements in gene therapy and increasing R&D funding. The growth of the market would be challenged by side effects of gene therapy and ethical and safety concerns and high cost of the treatment.

Get Free Research PDF Of The Report: https://www.researchmoz.us/enquiry.php?type=S&repid=2757028

The global gene therapy market has been segmented on the basis of cell type, vector type, application, end-user and region. Depending on the cell type, the market can be bifurcated into somatic cell gene therapy and germ cell gene therapy. According to the vector type, the global gene therapy market can be categorized into retrovirus & gammaretrovirus, adeno-associated viruses (AAV), lentivirus, adenovirus, modified herpes simplex virus and non-viral plasmid vector. Whereas, on the basis of application, the market can be split into oncological disorders, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases and others. Further, in terms of end-user, the global gene therapy market can broadly be segmented into hospitals, specialty treatment centers and other end-users.

The fastest growing regional market is North America due to the rising incidence of cancer and other target diseases, increasing favorable reimbursement scenario in the region and improvements in healthcare infrastructure. Further, the sudden outbreak of COVID-19 is causing an adverse disruption on the overall economy and society, affecting the rate of gene therapy procedures and clinical trials, which is expected to negatively impact the growth of the global gene therapy market during the forecasted period.

Scope of the report:

  • The report provides a comprehensive analysis of the global gene therapy market segmented on the basis of cell type, vector type, application, end-user and region.
  • The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co. (Celgene Corporation) and Gilead Sciences, Inc.) are also presented in detail.

Key Target Audience:

  • Gene Therapy Manufacturers
  • End Users (Hospitals, Specialty Treatment Centers & Others)
  • Research Institutes and Organizations
  • Government Bodies & Regulating Authorities

Enquiry For Discount Visit: https://www.researchmoz.us/enquiry.php?type=D&repid=2757028

Table of Content

1. Market Overview
1.1 Introduction
1.2 Diseases Treated by Gene Therapy
1.3 Process of Gene Therapy
1.4 Types of Gene Therapy
1.5 Application Areas for Gene Therapy
1.6 Gene Therapy Techniques
1.7 Advantages & Disadvantages of Gene Therapy

2. Impact of COVID-19
2.1 Economic Impact
2.2 Decline in Global GDP
2.3 Decline in Industrial Production
2.4 Impact on Gene Therapy
2.5 Impact on Clinical Trials of Gene Therapy

3. Global Market Analysis
3.1 Global Gene Therapy Market by Value
3.2 Global Gene Therapy Market Forecast by Value
3.3 Global Gene Therapy Market by Cell Type
3.3.1 Global Somatic Cell Gene Therapy Market by Value
3.3.2 Global Somatic Cell Gene Therapy Market Forecast by Value
3.3.3 Global Germ Cell Gene Therapy Market by Value
3.3.4 Global Germ Cell Gene Therapy Market Forecast by Value
3.4 Global Gene Therapy Market by Vector Type
3.4.1 Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value
3.4.2 Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value
3.4.3 Global Adeno-Associated Viruses Gene Therapy Market by Value
3.4.4 Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value
3.4.5 Global Lentivirus Gene Therapy Market by Value
3.4.6 Global Lentivirus Gene Therapy Market Forecast by Value
3.4.7 Global Adenovirus Gene Therapy Market by Value
3.4.8 Global Adenovirus Gene Therapy Market Forecast by Value
3.4.9 Global Modified Herpes Simplex Virus Gene Therapy Market by Value
3.4.10 Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value
3.4.11 Global Non-Viral Plasmid Vector Gene Therapy Market by Value
3.4.12 Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value
3.5 Global Gene Therapy Market by Application
3.5.1 Global Oncological Disorders Gene Therapy Market by Value
3.5.2 Global Oncological Disorders Gene Therapy Market Forecast by Value
3.5.3 Global Neurological Disorders Gene Therapy Market by Value
3.5.4 Global Neurological Disorders Gene Therapy Market Forecast by Value
3.5.5 Global Infectious Disease Gene Therapy Market by Value
3.5.6 Global Infectious Disease Gene Therapy Market Forecast by Value
3.5.7 Global Cardiovascular Diseases Gene Therapy Market by Value
3.5.8 Global Cardiovascular Diseases Gene Therapy Market Forecast by Value
3.5.9 Global Rare Diseases Gene Therapy Market by Value
3.5.10 Global Rare Diseases Gene Therapy Market Forecast by Value
3.6 Global Gene Therapy Market by End-User
3.6.1 Global Hospitals & Clinics Gene Therapy Market by Value
3.6.2 Global Hospitals & Clinics Gene Therapy Market Forecast by Value
3.6.3 Global Specialty Treatment Centers Gene Therapy Market by Value
3.6.4 Global Specialty Treatment Centers Gene Therapy Market Forecast by Value
3.7 Global Gene Therapy Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America Gene Therapy Market by Value
4.1.2 North America Gene Therapy Market Forecast by Value
4.2 Europe
4.2.1 Europe Gene Therapy Market by Value
4.2.2 Europe Gene Therapy Market Forecast by Value
4.2.3 Europe Gene Therapy Market by Indication
4.2.4 Europe Large B-Cell Lymphoma Gene Therapy Market by Value
4.2.5 Europe Large B-Cell Lymphoma Gene Therapy Market Forecast by Value
4.2.6 Europe Inherited Retinal Disease Gene Therapy Market by Value
4.2.7 Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value
4.2.8 Europe ADA-SCID Gene Therapy Market by Value
4.2.9 Europe ADA-SCID Gene Therapy Market Forecast by Value
4.2.10 Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value
4.2.11 Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Gene Therapy Market by Value
4.3.2 Asia Pacific Gene Therapy Market Forecast by Value
.4 RoW
4.4.1 RoW Gene Therapy Market by Value
4.4.2 RoW Gene Therapy Market Forecast by Value

Continue…

Inquire More About This Report: https://www.researchmoz.us/enquiry.php?type=E&repid=2757028

For More Information Kindly Contact:
ResearchMoz
Mr. Rohit Bhisey,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: [email protected]
Follow me on : http://marketresearchlatestreports.blogspot.com/